These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 19207543)

  • 1. Helicobacter pylori eradication: role of individual therapy constituents and therapy duration.
    Qasim A; O'Morain CA; O'Connor HJ
    Fundam Clin Pharmacol; 2009 Feb; 23(1):43-52. PubMed ID: 19207543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Helicobacter pylori eradication therapy in chronic liver disease.
    Jung SW; Lee SW; Hyun JJ; Kim DI; Koo JS; Yim HJ; Park JJ; Lee HS; Chun HJ; Um SH; Choi JH; Kim CD; Ryu HS
    Dig Liver Dis; 2009 Feb; 41(2):134-40. PubMed ID: 18436489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines in the medical treatment of Helicobacter pylori infection.
    Dzieniszewski J; Jarosz M
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():143-54. PubMed ID: 17033112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy.
    Sugimoto M; Furuta T; Shirai N; Kodaira C; Nishino M; Ikuma M; Ishizaki T; Hishida A
    Helicobacter; 2007 Aug; 12(4):317-23. PubMed ID: 17669104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years.
    Kadayifci A; Buyukhatipoglu H; Cemil Savas M; Simsek I
    Clin Ther; 2006 Nov; 28(11):1960-6. PubMed ID: 17213016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
    Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
    Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
    Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
    J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variables influencing outcome of Helicobacter pylori eradication therapy in South China.
    Cai W; Zhou L; Ren W; Deng L; Yu M
    Helicobacter; 2009 Oct; 14(5):91-6. PubMed ID: 19751433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of Helicobacter pylori infection].
    Treiber G
    Praxis (Bern 1994); 2000 May; 89(22):958-62. PubMed ID: 10893994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
    Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
    Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What is currently the Helicobacter pylori eradication therapy of choice? Triple therapy (PPI, amoxicillin and clarithromycin) or sequential therapy (PPI and amoxicillin for 5 days followed by PPI, clarithromycin and metronidazole for a further 5 days)?].
    Sánchez-Delgado J
    Gastroenterol Hepatol; 2009 Jan; 32(1):68-9. PubMed ID: 19174106
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of Helicobacter pylori infection.
    Egan BJ; Marzio L; O'Connor H; O'Morain C
    Helicobacter; 2008 Oct; 13 Suppl 1():35-40. PubMed ID: 18783520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic aspects of eradication therapy for Helicobacter pylori Infection.
    Furuta T; Graham DY
    Gastroenterol Clin North Am; 2010 Sep; 39(3):465-80. PubMed ID: 20951912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori eradication in peptic dyspepsia.
    Lule GN
    East Afr Med J; 2005 Dec; 82(12):601-2. PubMed ID: 16619702
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of Helicobacter pylori.
    Bytzer P; O'Morain C
    Helicobacter; 2005; 10 Suppl 1():40-6. PubMed ID: 16178970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori and non-malignant diseases.
    Rokkas T; Simsek I; Ladas S
    Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens.
    Filipec Kanizaj T; Katicic M; Skurla B; Ticak M; Plecko V; Kalenic S
    Helicobacter; 2009 Feb; 14(1):29-35. PubMed ID: 19191893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.